HALLIE REDDEN: Open Payments
NPI 1851155626 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $431 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $323 |
| Corium, LLC | 9 | $169 |
| Alkermes, Inc. | 6 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, Azstarys, ARISTADA, REXULTI, CAPLYTA, Auvelity, FANAPT, INGREZZA.
Industry payments across KY — which companies pay providers there.
